| PERIOD ENDING | 29-Mar-09 | 30-Mar-08 | 1-Apr-07 | | Total Revenue | 663,245 | 781,467 | 803,596 | | Cost of Revenue | 388,796 | 442,135 | 462,948 | | | Gross Profit | 274,449 | 339,332 | 340,648 | | | Operating Expenses | | Research Development | 161,192 | 165,599 | 166,433 | | Selling General and Administrative | 125,810 | 161,708 | 191,211 | | Non Recurring | 1,031,282 |
-
| 500 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (1,043,835) | 12,025 | (17,496) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,692) | 16,815 | 15,211 | | Earnings Before Interest And Taxes | (1,045,527) | 28,840 | (2,285) | | Interest Expense | 60 | 103 | 263 | | Income Before Tax | (1,045,587) | 28,737 | (2,548) | | Income Tax Expense | (420) | (5,442) | 5,030 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,045,167) | 34,179 | (7,578) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (1,045,167) | 34,179 | (7,578) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,045,167) | $34,179 | ($7,578) |
|
1.48% Nasdaq 
Income Statement
